The $3B Liquidity Advantage: Why Depo-Provera is the Strategic Play for 2025-2026

As many mass torts face defendants with thinning capital, the Depo-Provera litigation stands out for its defendant solvency. Pfizer holds massive liquidity, providing the “muscle” to absorb a global settlement without the existential risks seen in other recent litigations.

A Mature Docket with High Individual Value

With the JPML consolidating cases into MDL 3140 in the Northern District of Florida, the docket is maturing rapidly. Experts estimate that cases involving brain surgery, neurological damage, and permanent disability could reach settlement values in the mid-to-high six figures.

Timing is Everything

The “clean forecast” suggests that with discovery ongoing and bellwether trials expected by late 2026, the valuation of these cases will soon crystallize.

Building Your Inventory Safely

Mohr Marketing is helping firms position themselves at the front of this docket by delivering signed, vetted plaintiffs. Through our Compliance Shield, we ensure:

• Timeline Integrity: We verify usage occurred within the “failure to warn” window prior to the FDA’s recent label updates.
• Regulatory Peace of Mind: Every retainer includes TrustedForm or Jornaya certification, ensuring 100% TCPA compliance and documented consent.

Don’t wait for the first bellwether verdict to start building your list. The window to acquire high-quality cases at a manageable cost is open now.

Ready to fill your docket with valid cases?

Partner with Mohr Marketing to secure high-quality, compliant plaintiffs.

Contact Mohr Marketing to deploy the Compliance Shield today.

Click Here Get a Custom Quote

Read Press Release

Let’s discuss your specific needs and how our Compliance Program, AI Lead Generation Technology, digital marketing, and mass tort cases can help you achieve your growth goals.

www.mohrmktg.com 

Mohr Marketing Team

Summary

Article Name

Why Depo-Provera is the Strategic Play for 2025-2026

Description

The $3B Liquidity Advantage: Why Depo-Provera is the Strategic Play for 2026–2027. The Depo-Provera litigation stands out for its defendant solvency.

Author

Mohr Marketing Team

Publisher Name

Mohr Marketing, LLC

Publisher Logo